Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Safety of Live-Attenuated Vaccination in Pediatric Patients Receiving Dupilumab: A Multicenter Retrospective Study.
Journal: Journal of the American Academy of Dermatology
Published: February 22, 2026
Signals for mineralization and inflammation are observed following treatment with fasinumab, a specific nerve growth factor inhibitor.
Journal: Osteoarthritis and cartilage
Published: February 10, 2026
Validation of the atopic dermatitis control tool in pediatric patients with atopic dermatitis.
Journal: Journal of the American Academy of Dermatology
Published: June 30, 2025
Investigating the Use of Melatonin in Children With Atopic Dermatitis: A Cross-Sectional Study.
Journal: Pediatric dermatology
Published: May 16, 2025
The Effects of Fasinumab on Peripheral Nerve Function and Ganglion Anatomy: Results From a Randomized, Double-Blind, Placebo-Controlled Study in Patients With Pain Due to Osteoarthritis of the Knee or Hip, and a Series of Nonclinical Studies.
Journal: Current therapeutic research, clinical and experimental
Published: May 07, 2025
Continuous Subcutaneous Insulin Infusion (CSII)-Associated Granulomatous Suppurative Reaction in Four Children With Type 1 Diabetes.
Journal: Pediatric dermatology
Published: April 30, 2025
Identification of alkaline phosphatase as a putative biomarker of anti-NGF treatment-associated arthropathies: Machine learning-assisted analyses of clinical trial data.
Journal: Osteoarthritis and cartilage open
Published: April 07, 2025
Corrigendum to 'A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology' [Annals of Allergy, Asthma & Immunology 133/3 (2024) 286-94].
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: November 03, 2024
Efficacy and safety of fasinumab in an NSAID-controlled study in patients with pain due to osteoarthritis of the knee or hip.
Journal: BMC musculoskeletal disorders
Published: July 26, 2024
A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip.
Journal: Osteoarthritis and cartilage open
Published: July 19, 2024
Last Updated: 09/26/2026